Company Directory > Pharma > Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (CTTQ)
CTTQ is a leading multinational pharmaceutical company based in China, serving as the core enterprise of Sino Biopharmaceutical Limited (01177.HK). The company integrates R&D, manufacturing, marketing, and distribution, with a strong focus on innovative drug development in therapeutic areas such as oncology, liver disease, respiratory diseases, infectious diseases, and diabetes. With a history dating back to 1969, CTTQ has established itself as one of China's top pharmaceutical enterprises. It operates multiple R&D centers and manufacturing plants, maintaining a significant presence in both domestic and international markets, including exports to Europe and the United States.
CLASSIFICATION
Company Type:Pharma
Industry:Pharmaceuticals
Sub-Industry:Oncology, Liver Disease, Respiratory, Infectious Disease
SIZE & FINANCIALS
Employees:10000+
Revenue:$3B+
Founded:1969
Ownership:subsidiary
Status:operating
STOCK
Exchange:HKEX
Ticker:01177.HK (Parent: Sino Biopharmaceutical)
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Small molecule, Monoclonal antibody, Biosimilars, Chemical drugs
Active Trials:900
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Parent Company:Sino Biopharmaceutical Limited
Key Partnerships:Harbour BioMed (Biologics collaboration), Shionogi (Ensitrelvir promotion), BioLineRx (Hepatitis C drug)
COMPETITION
Position:Leader
LEADERSHIP
Key Executives:
Kang Xin Yu - CEO
LINKS
Website:cttq.com
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (CTTQ) and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (CTTQ). The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.